EUVIMEDEUVIMED entdecken
Fallbericht

Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue–Based Products

Robert P Dickson, Deborah A Dingell

JAMA · 2024

DOI: 10.1001/jama.2024.6834 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JAMA, 2024. Verfasst von Robert P Dickson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Washtenaw County Tuberculosis Program, Ypsilanti, Michigan. Hauptthemen laut MEDLINE: Government Regulation, United States Food and Drug Administration, Bone Transplantation, Bone and Bones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Viewpoint discusses the death of a patient caused by unregulated biological products and efforts to encourage federal government oversight of such products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Government RegulationUnited States Food and Drug AdministrationBone TransplantationBone and BonesTuberculosisDisease OutbreaksHumansCell- and Tissue-Based TherapyTissue BanksUnited StatesMycobacterium tuberculosisFemaleMiddle Aged

Autor:innen und Institutionen

  • Washtenaw County Tuberculosis Program, Ypsilanti, Michigan.
  • University of Michigan Medical School, Ann Arbor.
  • US House of Representatives, Washington, DC.

Zitieren

APA

Dickson, R. P., & Dingell, D. A. (2024). Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue–Based Products. JAMA. https://doi.org/10.1001/jama.2024.6834

Vancouver

Dickson RP, Dingell DA. Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue–Based Products. JAMA. 2024. doi:10.1001/jama.2024.6834

BibTeX
@article{Dickson2024,
  author = {Dickson, Robert P and Dingell, Deborah A},
  title = {Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue–Based Products},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.6834}
}
Kostenlos starten →